Navigation Links
Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
Date:7/25/2012

NATICK, Mass., July 25, 2012 /PRNewswire/ -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, announced dosing of patients in the first-in-human clinical trials with KPT-330. KPT-330 is the first oral SINE CRM1 antagonist to enter human studies.  SINEs specifically and irreversibly inhibit the nuclear export protein CRM1 (chromosome region maintenance protein 1), also called exportin 1 (XPO1).  CRM1 is the exclusive mediator of nuclear export of p53, p73, pRb, FOXO, p21, p27, BRACA1, the endogenous inhibitor of Nuclear Factor kB (NF-kB) known as IkB, and other tumor suppressor and growth regulatory proteins. Nuclear export of these key proteins leads to their functional inactivation.  Blockade of CRM1 leads to accumulation and activation of tumor suppressor and growth regulatory proteins in the nucleus, leading to potent and selective tumor cell apoptosis while sparing normal cells. 

(Logo:  http://photos.prnewswire.com/prnh/20120508/NE02031LOGO )

Patient dosing has been initiated in two phase 1 studies.  The primary endpoints of both studies are to determine the safety and tolerability profile and the maximum tolerated dose of KPT-330 given orally 2-3 times per week. The first study includes patients with advanced solid tumors whose disease has progressed after at least one prior therapy for metastatic disease (NCT01607905).  The second study includes patients with advanced hematologic malignancies including chronic lymphocytic leukemia, non-Hodgkin's lymphoma, multiple myeloma, and Waldenstrom's macroglobulinemia whose disease has relapsed after standard therapies (NCT01607892). Sharon Shacham, PhD, MBA, Karyopharm's Founder, Chief Scientific Officer, and head of research and development commented, "The initiation of these two Phase 1 trials with KPT-330 is a key milestone since the closing of our Series
'/>"/>

SOURCE Karyopharm Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
2. PTC Therapeutics Closes $30 Million Financing
3. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
4. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
5. Echo Therapeutics Expands License Agreement with Ferndale Pharma
6. PTC Therapeutics Announces Achievement of Major Milestone in Wellcome Trust BMI1 Collaboration
7. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
8. NIPTE Will Participate in NIHs Therapeutics for Rare and Neglected Diseases (TRND) Program
9. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
10. Frost & Sullivan: European Bipolar Therapeutics Market Slows Down in the Short Term As Key Blockbuster Drugs Go Off Patent
11. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 , Joint research by ... from Biostar , Published in ,Stem Cells Translational ... lifespan through multiple IV administration of Adipose-derived MSC ... expectancy found , Commercialization within 5 years expected ... possibility that adult mesenchymal stem cells (MSCs) may extend ...
(Date:8/28/2015)... SAN FRANCISCO , August 28, 2015 ... is expected to reach USD 49.12 billion by 2020, ... 2020, according to a new report by Grand View ... an estimated CAGR of 49.7% from 2014 to 2020. ... Growing aging population along with rising incidences of ...
(Date:8/27/2015)... Aug. 27, 2015 Biosimilars are not ... the U.S. Food and Drug Administration (FDA) for ... in its draft guidance issued today. The FDA,s ... proposes distinguishable names, calling for biological products to ... suffix. This proposal reflects the agency,s thinking that ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... Lytle LLP, one of the region,s best known law ... Court in Rochester, upheld a high-profile products liability verdict ... In its decision, the Fourth Department judicial panel found ... of Cheektowaga, NY a quadriplegic.  In making its findings, ...
... 18, 2011 The U.S. Food and Drug Administration ... (neovascular) age-related macular degeneration (AMD), a leading cause of ... older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... affects the macula, the part of the eye that ...
Cached Medicine Technology:The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 2The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 3FDA Approves Eylea for Eye Disorder in Older People 2
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol ... Strawbridge, gives a new approach on solutions in his new book ":Unraveling The ... and employees getting together for meaningful group meetings. "This would educate the employees ...
(Date:8/28/2015)... ... August 28, 2015 , ... The ... honoring military veterans leading in business. Mr. Troy Mizell, Chairman of the ... inaugural Nashville Business Journal's 2015 Veterans Awards will recognize Nashville military veterans who, ...
(Date:8/28/2015)... ... ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain ... pain, neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his ... on to earn his title of Doctor of Chiropractic from the Palmer College of ...
(Date:8/28/2015)... ... 28, 2015 , ... The Quatela Center for Plastic Surgery is excited to ... nonsurgical product approved by the Food and Drug Administration to eliminate submental fat, also ... William Koenig are among the premier cosmetic surgeons in Rochester to offer this ...
(Date:8/28/2015)... ... August 28, 2015 , ... Mendon, IL, home of the Adams County ... people, all for a good cause. In its second year, the “Music With A ... Best Drug Rehabilitation. The “Mission” of “Music With A Mission” is to raise money ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2
... Former NFL player and Dallas Cowboy,Jason Kaiser received top ... Kaiser earned the title of,valedictorian with a GPA of ... school and in my class especially," he said. "To ... in Parker College, Kaiser played professional football,for more than ...
... less blood loss, shorter hospital stays, study finds , , ... surgery to remove pancreatic tumors or cysts leads to ... finds. , In laparoscopic surgery, doctors make smaller ... with fiber optics and video cameras. This less invasive ...
... - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) today reported financial ... specified otherwise, all amounts are in U.S. dollars,and in ... of 2008, we were pleased to report the U.S. ... for blood,monitoring from the Aczone(TM) label," said Bob Butchofsky, ...
... MAPP ) today announced that the company will,present at ... 2008:, Morgan Stanley Global Healthcare Conference, Key Biscayne, ... Time, Deutsche Bank 33rd Annual Health Care Conference, Boston, ... Time A live webcast of the presentations will be ...
... HILL, N.C., April 25 Managing multi-generational,diversity is ... recent,benchmarking study with 23 leading companies, 80 percent ... and yet only one-third say,their companies offer training ... to download an excerpt of,this new research, The ...
... Today, on World Malaria,Day, the American Red Cross is ... robust global response to this deadly disease., Each ... 300 million people, mostly children in Africa. More,than 1 ... Since 2001, the American Red Cross and its ...
Cached Medicine News:Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 2Health News:Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate 3Health News:Laparoscopic Surgery on Pancreas Has Fewer Complications 2Health News:QLT announces first quarter results for 2008 2Health News:QLT announces first quarter results for 2008 3Health News:QLT announces first quarter results for 2008 4Health News:QLT announces first quarter results for 2008 5Health News:QLT announces first quarter results for 2008 6Health News:QLT announces first quarter results for 2008 7Health News:QLT announces first quarter results for 2008 8Health News:QLT announces first quarter results for 2008 9Health News:QLT announces first quarter results for 2008 10Health News:QLT announces first quarter results for 2008 11Health News:QLT announces first quarter results for 2008 12Health News:QLT announces first quarter results for 2008 13Health News:QLT announces first quarter results for 2008 14Health News:MAP Pharmaceuticals to Present at Upcoming Investor Conferences 2Health News:Multi-generational Diversity Top Challenge for Businesses Today: Leading Company to Share Insights June 4-6 2Health News:Uniting to Fight Malaria Around the World 2Health News:Uniting to Fight Malaria Around the World 3
Two prong stainless steel tips; with titanium handle/...
Straight shaft with fine pointed 0.3mm Tips for Grasping Delicate Capsule; In Titanium....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
Medicine Products: